- Home
- FRPT vs ACLX Comparison
FRPT vs ACLX Comparison
Compare FRPT & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRPT | ACLX |
|---|---|---|
| Founded | 2004 | 2015 |
| Country | United States | United States |
| Employees | 1288 | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.7B |
| IPO Year | 2014 | 2022 |
Fundamental Metrics
Financial Performance| Metric | FRPT | ACLX |
|---|---|---|
| Price | $85.73 | $114.48 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 15 |
| Target Price | $80.44 | ★ $115.85 |
| AVG Volume (30 Days) | 1.3M | ★ 3.4M |
| Earning Date | 05-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 183.87 | N/A |
| EPS | ★ 2.64 | N/A |
| Revenue | ★ $1,102,015,000.00 | $22,286,000.00 |
| Revenue This Year | $11.89 | $329.40 |
| Revenue Next Year | $9.49 | $151.37 |
| P/E Ratio | $32.38 | ★ N/A |
| Revenue Growth | ★ 13.01 | N/A |
| 52 Week Low | $46.76 | $47.86 |
| 52 Week High | $97.00 | $114.65 |
Technical Indicators
Market Signals| Indicator | FRPT | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 77.41 | 83.78 |
| Support Level | $66.11 | $64.61 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 3.61 | 1.25 |
| MACD | 0.87 | 2.97 |
| Stochastic Oscillator | 95.98 | 99.47 |
Price Performance
Historical ComparisonAbout FRPT Freshpet Inc.
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (96% of 2024 sales), with cats and treats comprising the rest of its sales. Geographically, the company's home US market, where all its food is produced, accounts for about 98% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.